hashimoto disease and glp-1 The Thyroid Twist: How Agonists Are Influencing Autoimmune Thyroid Care Can You Take GLP-1 Medications

Among participants in the semaglutide study who smoked cigarettes, those receiving the medication reported a steeper drop in daily cigarette use compared to those on placebo

This expands your patient pool

Subcutaneous liraglutide 3 mg (once daily) and semaglutide 2.4 mg (once weekly) have been approved for obesity management and a higher dose of subcutaneous semaglutide (7.2 mg once weekly) is currently assessed in a phase 3 trial (Table 1)

Researchers noted that even though these symptoms dont affect everyone, millions of people around the world are using semaglutide drugs, and hundreds of thousands could end up suffering